EIKN Insider Trading Activity and SEC Form 4 Filings
EIKN insider trading summary
Over the past 12 months, insiders at Eikon Therapeutics, Inc. (EIKN) reported 48 open-market purchases worth $340.7M by 23 insiders and no sales on SEC Form 4. Net insider buying was $340.7M.
Latest EIKN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 3, 2026 | Column Group IV, LP | Insider | Buy | $1.0M (89,200 @ $11.56) |
| Sep 3, 2026 | Column Group IV GP, LP | Insider | Buy | $1.0M (89,200 @ $11.56) |
| Sep 3, 2026 | TCG Opportunity III GP, LLC | Insider | Buy | $1.0M (89,200 @ $11.56) |
| Sep 3, 2026 | Column Group IV-A, LP | Insider | Buy | $1.0M (89,200 @ $11.56) |
| Sep 3, 2026 | Tim Kutzkey | Insider | Buy | $1.0M (89,200 @ $11.56) |
| Sep 3, 2026 | Peter Svennilson | Insider | Buy | $1.0M (89,200 @ $11.56) |
| Sep 3, 2026 | Column Group Opportunity III, LP | Insider | Buy | $1.0M (89,200 @ $11.56) |
| Sep 3, 2026 | Column Group Opportunity III GP, LP | Insider | Buy | $1.0M (89,200 @ $11.56) |
| Feb 6, 2026 | Tim Kutzkey | Insider | Buy | $25.9M (1,437,323 @ $18.00) |
| Feb 6, 2026 | TCG Opportunity III GP, LLC | Insider | Buy | $25.9M (1,437,323 @ $18.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.